Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship
出版年份 2020 全文链接
标题
Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship
作者
关键词
-
出版物
Antibiotics-Basel
Volume 9, Issue 10, Pages 671
出版商
MDPI AG
发表日期
2020-10-05
DOI
10.3390/antibiotics9100671
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)
- (2020) Olga P. Nyssen et al. HELICOBACTER
- European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners
- (2020) David Y Graham et al. GUT
- Vonoprazan‐containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance
- (2020) David Y Graham et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori
- (2019) Olga P. Nyssen et al. HELICOBACTER
- Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori
- (2019) Takahisa Furuta et al. DIGESTION
- Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency
- (2018) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States
- (2018) Hashem B. El-Serag et al. Clinical Gastroenterology and Hepatology
- Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions
- (2018) Alessia Savoldi et al. GASTROENTEROLOGY
- Update on the Use of Vonoprazan: A Competitive Acid Blocker
- (2018) David Y. Graham et al. GASTROENTEROLOGY
- Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies
- (2018) David Y. Graham et al. Expert Review of Anti-Infective Therapy
- Illusions regardingHelicobacter pyloriclinical trials and treatment guidelines
- (2017) David Y Graham GUT
- Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
- (2017) Bich N. Dang et al. Nature Reviews Gastroenterology & Hepatology
- Helicobacter pyloritherapy: a paradigm shift
- (2016) David Y. Graham et al. Expert Review of Anti-Infective Therapy
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
- (2016) Carlo A. Fallone et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Role of bismuth in improvingHelicobacter pylorieradication with triple therapy
- (2016) Maria Pina Dore et al. GUT
- High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
- (2015) Jyh-Chin Yang et al. Clinical Gastroenterology and Hepatology
- How to Effectively Use Bismuth Quadruple Therapy
- (2015) David Y. Graham et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- Hp-normogram (normo-graham) for Assessing the Outcome ofH. pyloriTherapy: Effect of Resistance, Duration, and CYP2C19 Genotype
- (2015) David Y. Graham HELICOBACTER
- Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection
- (2015) William M. Geisler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
- (2013) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
- (2012) CLINICAL INFECTIOUS DISEASES
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
- (2012) Jyh-Ming Liou et al. LANCET
- Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection
- (2011) Stephan Miehlke et al. HELICOBACTER
- Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results
- (2010) David Y. Graham Clinical Gastroenterology and Hepatology
- Sequential Metronidazole-Furazolidone or Clarithromycin-Furazolidone Compared to Clarithromycin-Based Quadruple Regimens for the Eradication of Helicobacter pylori in Peptic Ulcer Disease: A Double-Blind Randomized Controlled Trial
- (2010) Saghi Riahizadeh et al. HELICOBACTER
- Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies
- (2008) David Y. Graham Clinical Gastroenterology and Hepatology
- New concepts of resistance in the treatment of Helicobacter pylori infections
- (2008) David Y Graham et al. Nature clinical practice. Gastroenterology & hepatology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started